Stocks in the news: Lupin, Fortis Healthcare, Indian Hotels, NHPC, AstraZeneca, Vedanta, Shalby, Andhra Bank

Indian Hotels: Company enters Saudi with first Taj hotel in Makkah

NHPC: Company's 50 MW solar project synced with grid, Hindu Business Line reported.

China’s Fosun enters race to buy Fortis Healthcare

5paisa Capital Q4FY18 results YoY; reported loss of Rs 6 crore versus Rs 3 crore; revenue at Rs 7.87 crore versus Rs 4.60 crore

Tata Sponge Q4FY18 results YoY; net sales up 45.7 percent at Rs 243.5 crore versus Rs 167.17 crore; operating profit up 139 percent at Rs 61.6 crore versus Rs 25.82 crore; margins at 25.3 percent versus 13.95 percent; profit up 120 percent at Rs 46.7 crore versus Rs 21.2 crore

Dalmia Bharat alleges information leakage in Binani Cement bidding process: BS

Hindustan Zinc plans to produce 1000 tonnes of silver in next 3-4 years: BS

United Spirits moves HC alleging that government outlets in Chattisgarh are not buying their products and are trying to drive them out: Media Report

Filatex India board meeting on May 7 to consider stock split and Q4 results

Virinchi signs multi-product 5-year contract with Advance America Inc for its flagship management software QFund

Andhra Bank says exposure to SSK Trading of Rs 30 crore was classified NPA in June 2014: Reuters

HAL enhanced jet production capacity: BQ

Indian Hotel enters into Saudi Arabia with 340 keys properties in Makkan

Blue Star launched 100 products during summers and target to have Rs 1,700 crore revenue from ACs

Future Consumer increased stake to 99.93 percent in Integrated Food Park, company's subsidiary, acquired the stake from Capital Foods pvt ltd

Hotel Leela Venture notified exchange about default in payment of interest and principal of debentures

Lupin: Company receives tentative US FDA approval for generic AndroGel.

AstraZeneca: Company to invest USD 90 million over the next five years in India.

Ashiana Housing - CARE reaffirmed the issuer rating at A

Oberoi Realty board meeting on April 24 to consider dividend for FY17-18, Q4FY18 Results; also to consider fund raising via NCD/QIP

Sequent Scientific's subsidiary acquired Bremer Pharma GMBH at Enterprise value of Euro 22,63,431

KP Energy has fixed record date for bonus shares as April 27O

Omaxe to incorporate wholly owned subsidiary Company as Omaxe New Faridabad Developers Pvt Ltd

Cadila Healthcare has divested its entire shareholding in Bremer Pharma GmbH, wholly owned subsidiary of company

Fortis Healthcare confirmed that company has availed a secured financing facility upto Rs 160 crore from RattanIndia Finance Pvt Ltd

Andhra Bank: Exposure to SSK Trading of Rs 30 crore is non performing asset, Bloomberg reported.

Jagran Prakashan: Company to consider share buyback on April 27.

Vedanta: Company's resolution plan for Electrosteel Steels approved by NCLT.

Shalby: Company signs memorandum of understanding with Sen Sok International University Hospital, Cambodia